Northside Hospital Opens Fifth Health Choice Urgent Care Center in Chamblee, Georgia

Northside Hospital and Urgent Care Group announce the opening of Health Choice Urgent Care in Chamblee, Georgia.

The Northside and Urgent Care Group joint venture now owns and operates five Health Choice Urgent Care centers serving the Greater Atlanta area. Health Choice Urgent Care has been voted Best of Gwinnett four years in a row and Health Choice – Chamblee is the joint-venture’s first center in Dekalb county.

Health Choice – Chamblee, along with all other Health Choice centers, offer walk-in urgent care and occupational health services 7 days a week from 8:00 AM – 8:00 PM. Additionally, Health Choice centers accept all major insurance, have affordable self-pay options and are VA Authorized urgent care providers. For more information about services and locations, please visit here.

“We are pleased to continue to grow our partnership with Northside Hospital through the opening of Health Choice – Chamblee,” said David Maloney, CEO of Urgent Care Group. “Health Choice will offer the Chamblee community access to convenient and affordable on-demand healthcare. Our team is ready and excited to welcome patients into our new center!”

Health Choice Urgent Care will be celebrating the new Chamblee center with a ribbon cutting ceremony on November 10, 2021, at 1:00 PM ET. This event will take place at Health Choice – Chamblee, 5255 Peachtree Blvd Suite 102 Chamblee, GA 30341 on the Ground floor of The Attiva apartment building, across from Dyer & Dyer Volvo.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy